Moneycontrol
/home/moneycontrol/commonstore/commonfiles/headband_data_live.json
Array
(
    [0] => Array
        (
            [title] => Exclusive keynote by MSME Minister Nitin Gadkari at Small Business Virtual Summit with CISCO on 17th July - Register Now
            [lp_url] => https://www.moneycontrol.com/cisco-smb-virtual-summit/?utm_source=moneycontrol&utm_medium=headband&utm_campaign=cisco_smb
            [ga_event_tracker] => Array
                (
                    [category] => Register-webinar
                    [action] => From-Home
                    [label] => Register-webinar
                )

            [start_date] => 2020-07-08 00:00:00
            [start_date_epoch] => 1594146600
            [end_date] => 2020-07-10 16:00:00
            [end_date_epoch] => 1594377000
            [rank] => 1
        )

    [1] => Array
        (
            [title] => LIVE Webinar: RSI - 5 Star Trading Strategy Webinar by Vishal B. Malkan . Watch Now!
            [lp_url] => https://www.moneycontrol.com/ms/malkansviews/?utm_source=Moneycontrol&utm_medium=Headdband
            [ga_event_tracker] => Array
                (
                    [category] => Watchnow-webinar
                    [action] => From-Home
                    [label] => Watchnow-webinar
                )

            [start_date] => 2020-07-10 16:00:00
            [start_date_epoch] => 1594377000
            [end_date] => 2020-07-10 17:00:00
            [end_date_epoch] => 1594380600
            [rank] => 2
        )

    [2] => Array
        (
            [title] => Tune in on 17th July for the Small Business Virtual Summit with Cisco. Register now!
            [lp_url] => https://www.moneycontrol.com/cisco-smb-virtual-summit/?utm_source=moneycontrol&utm_medium=headband&utm_campaign=cisco_smb
            [ga_event_tracker] => Array
                (
                    [category] => Register-webinar
                    [action] => From-Home
                    [label] => Register-webinar
                )

            [start_date] => 2020-07-10 17:00:00
            [start_date_epoch] => 1594380600
            [end_date] => 2020-07-17 11:00:00
            [end_date_epoch] => 1594963800
            [rank] => 3
        )

    [3] => Array
        (
            [title] => Special Offer: Subscribe to Moneycontrol PRO at ₹1 per day for the first year. Use Coupon: PRO365.
            [lp_url] => https://www.moneycontrol.com/promos/pro.php
            [ga_event_tracker] => Array
                (
                    [category] => PRO365
                    [action] => From-Home
                    [label] => Ribbon
                )

            [start_date] => 2020-07-17 11:00:00
            [start_date_epoch] => 1594963800
            [end_date] => 2020-07-31 23:00:00
            [end_date_epoch] => 1596216600
            [rank] => 4
        )

)
Array
(
    [count] => 1
    [data] => Array
        (
            [0] => Array
                (
                    [title] => Tune in on 17th July for the Small Business Virtual Summit with Cisco. Register now!
                    [link] => https://www.moneycontrol.com/cisco-smb-virtual-summit/?utm_source=moneycontrol&utm_medium=headband&utm_campaign=cisco_smb
                    [ga_event_tracker] => Array
                        (
                            [category] => Top Band
                            [action] => Virtual Summit
                            [label] => From-Home
                        )

                )

        )

)
Tune in on 17th July for the Small Business Virtual Summit with Cisco. Register now!
you are here: HomeNewsWorld
Last Updated : Jun 02, 2020 12:59 PM IST | Source: Reuters

Russia to roll out its first approved COVID-19 drug next week

Russian hospitals can begin giving the antiviral drug, which is registered under the name Avifavir, to patients from June 11, the head of Russia’s RDIF sovereign wealth fund told Reuters in an interview. He said the company behind the drug would manufacture enough to treat around 60,000 people a month.

Reuters
Representative image
Representative image

Russia will start giving its first drug approved to treat COVID-19 to patients next week, its state financial backer told Reuters, a move it hopes will ease strains on the health system and speed a return to normal economic life.

Russian hospitals can begin giving the antiviral drug, which is registered under the name Avifavir, to patients from June 11, the head of Russia’s RDIF sovereign wealth fund told Reuters in an interview. He said the company behind the drug would manufacture enough to treat around 60,000 people a month.

There is currently no vaccine for COVID-19, the disease caused by the new coronavirus, and human trials of several existing antiviral drugs have yet to show efficacy.

Close

A new antiviral drug from Gilead called remdesivir has shown some promise in small efficacy trials against COVID-19 and is being given to patients by some countries under compassionate or emergency use rules.

Avifavir, known generically as favipiravir, was first developed in the late 1990s by a Japanese company later bought by Fujifilm as it moved into healthcare.

RDIF head Kirill Dmitriev said Russian scientists had modified the drug to enhance it, and said Moscow would be ready to share the details of those modifications within two weeks.

Japan has been trialling the same drug, known there as Avigan. It has won plaudits from Prime Minister Shinzo Abe and $128 million in government funding, but has yet to be approved for use.

Avifavir appeared on a Russian government list of approved drugs on Saturday.

ACCELERATED PROCESS

Dmitriev said clinical trials of the drug had been conducted involving 330 people, and had shown that it successfully treated the virus in most cases within four days.
First Published on Jun 2, 2020 12:59 pm
Sections